| Dr Michael Le Nhat Thien Vu, PHARMD | |
|
1644 Jutland Dr, Marrero, LA 70072-4331 | |
| (209) 915-8111 | |
| Not Available |
| Full Name | Dr Michael Le Nhat Thien Vu |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1644 Jutland Dr, Marrero, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194126672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 020773 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Le Nhat Thien Vu, PHARMD 1644 Jutland Dr, Marrero, LA 70072-4331 Ph: (209) 915-8111 | Dr Michael Le Nhat Thien Vu, PHARMD 1644 Jutland Dr, Marrero, LA 70072-4331 Ph: (209) 915-8111 |
News Archive
Scientists at Cold Spring Harbor Laboratory have devised a powerful algorithm that improves the effectiveness of an important research technology harnessing RNA interference, or RNAi.
Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
Thyroid carcinoma is the third most common tumor malignancy in children. This pediatric cancer shares several characteristics with adult thyroid cancer patients including common cellular subtypes that are papillary, follicular and medullary; a female to male ratio is approximately 6:1; and a cervical nodal disease that can be observed at the time of presentation in 30-60 percent in both papillary and follicular malignancies.
› Verified 6 days ago
Jennifer Thuy Phan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4810 Lapalco Blvd, Marrero, LA 70072 Phone: 504-341-1363 | |
Kalaina Price, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1950 Barataria Blvd, Marrero, LA 70072 Phone: 504-325-7348 | |
Dr. Alicia Aguiar Fernandez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5001 Westbank Expy, Marrero, LA 70072 Phone: 504-218-2278 | |
Dr. Jonas Herbert Terry, PHARMD., B.S. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2641 Sea Shore Dr, Marrero, LA 70072 Phone: 504-947-6115 | |
Mr. Nicolas Pablo Hernandez Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2564 Barataria Blvd, Marrero, LA 70072 Phone: 504-340-3592 Fax: 504-340-3617 | |
Mr. Karl David Matherne, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Westbank Expy, Marrero, LA 70072 Phone: 504-340-6337 Fax: 504-340-1636 | |
Erica M Thompson, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 Avenue C, Marrero, LA 70072 Phone: 504-236-1730 |